https://www.selleckchem.com/pr....oducts/ag-1024-tyrph
An amendment to this paper has been published and can be accessed via a link at the top of the paper.Therapeutic resistance continues to be an indominable foe in our ambition for curative cancer treatment. Recent insights into the molecular determinants of acquired treatment resistance in the clinical and experimental setting have challenged the widely held view of sequential genetic evolution as the primary cause of resistance and brought into sharp focus a range of non-genetic adaptive mechanisms. Notably, the genetic lands
Like
Comment
Share
